Nonhuman lentiviruses

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Evans, David T ^a   Elder, John H ^b   Desrosiers, Ronald C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974658510     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (384)

1. Aghokeng AF, Ayouba A, Mpoudi-Ngole E, et al. Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions. Infect Genet Evol 2010;10:386-396.
2. Agy MB, Frumkin LR, Corey L, et al. Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science 1992;257:103-106.
3. Alexander L, Du Z, Rosenzweig M, et al. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol 1997;71:6094-6099.
4. Alexander L, Illyinskii PO, Lang SM, et al. Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys. J Virol 2003;77:6823-6835.
5. Allan JS, Short M, Taylor ME, et al. Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol 1991;65:2816-2828.
6. Allan JS, Strauss J, Buck DW. Enhancement of SIV infection with soluble receptor molecules. Science 1990;247:1084-1088.
7. Ambrose Z, Boltz V, Palmer S, et al. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J Virol 2004;78:13553-13561.
8. Apetrei C, Kaur A, Lerche NW, et al. Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol 2005;79:8991-9005.
9. Arthur LO, Bess JW Jr, Sowder RC II, et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992;258:1935-1938.
10. Arthur LO, Bess JW Jr, Urban RG, et al. Macaques immunized with HLA-DR are protected from SIV challenge. J Virol 1995;69:3117-3124.
11. Bailes E, Gao F, Bibollet-Ruche F, et al. Hybrid origin of SIV in chimpanzees. Science 2003;300:1713.
12. Baldo AM, McClure MA. Evolution and horizontal transfer of dUTPase-encoding genes in viruses and their hosts. J Virol 1999;73:7710-7721.
13. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-871.
14. Beale RC, Petersen-Mahrt SK, Watt IN, et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J Mol Biol 2004;337:585-596.
15. Beer BE, Bailes E, Goeken R, et al. Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies. J Virol 1999;73:7734-7744.
16. Beer BE, Foley BT, Kuiken CL, et al. Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411). J Virol 2001;75:12014-12027.
17. Beisel CE, Edwards JF, Dunn LL, et al. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J Virol 1993;67:832-842.
18. Benveniste RE, Arthur LO, Tsai C-C, et al. Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. J Virol 1986;60:483-490.
19. Bibollet-Ruche F, Bailes E, Gao F, et al. New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade. J Virol 2004;78:7748-7762.
20. Bibollet-Ruche F, Galat-Luong A, Cuny G, et al. Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild. J Gen Virol 1996;77:773-781.
21. Bishop KN, Holmes RK, Sheehy AM, et al. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol 2004;14:1392-1396.
22. Bogerd HP, Doehle BP, Wiegand HL, et al. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A 2004;101:3770-3774.
23. Bogerd HP, Wiegand HL, Bieniasz PD, et al. Functional differences between human and bovine immunodeficiency virus tat transcription factors. J Virol 2000;74:4666-4671.
24. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997;3:205-211.
25. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-1371.
26. Brenchley JM, Schacker TW, Ruff LE, et al. CD4 +T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004;200:749-759.
27. Brennan G, Kozyrev Y, Hu SL. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc Natl Acad Sci U S A 2008;105:3569-3574.
28. Brindley MA, Maury W. Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis. J Virol 2008;82:1628-1637.
29. Brindley MA, Zhang B, Montelaro RC, et al. An equine infectious anemia virus variant superinfects cells through novel receptor interactions. J Virol 2008;82:9425-9432.
30. Broussard SR, Staprans SI, White R, et al. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 2001;75:2262-2275.
31. Burns D, Collignon, C, Desrosiers, RC. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol 1993;67:4104-4113.
32. Burns D, Desrosiers, RC. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol 1991;65:1843-1854.
33. Campbell R, Robinson, WF. The comparative pathology of the lentiviruses. J Comp Path 1998;119:333-395.
34. Carpenter MA, Brown EW, Culver M, et al. Genetic and phylogenetic divergence of feline immunodeficiency virus in the puma (Puma concolor). J Virol 1996;70:6682-6693.
35. Chackerian B, Rudensey LM, Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus that evolve in the host alter recognition by neutralizing antibodies. J Virol 1997;71:7719-7727.
36. Chadwick BJ, Coelen RJ, Wilcox GE, et al. Nucleotide sequence analysis of Jembrana disease virus: a bovine lentivirus associated with an acute disease syndrome. J Gen Virol 1995;76:1637-1650.
37. Chatterji U, de Parseval A, Elder JH. Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J Virol 2002;76:9624-9634.
38. Chelico L, Pham P, Calabrese P, et al. APOBEC3G DNA deaminase acts processively 3' -> 5' on single-stranded DNA. Nat Struct Mol Biol 2006;13:392-399.
39. Chen B, Vogan EM, Gong H, et al. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005;433:834-841.
40. Chen Z, Kwon D, Jin Z, et al. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med 1998;188:2057-2065.
41. Chen Z, Luckay A, Sodora DL, et al. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol 1997;71:3953-3960.
42. Chen Z, Telfier P, Gettie A, et al. Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J Virol 1996;70:3617-3627.
43. Cheng-Mayer C, Brown A, Harouse J, et al. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol 1999;73:5294-5300.
44. Chowers MY, Spina CA, Kwob TJ, et al. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 1994;68:2906-2914.
45. Clavel F, Guetaro D, Brun-Vezinet F, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986;233:343-346.
46. Clewley JP, Lewis JC, Brown DW, et al. A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus. J Virol 1998;72:10305-10309.
47. Cohen GB, Gandhi RT, Davis DM, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999;10:661-671.
48. Collins KL, Chen BK, Kalams SA, et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
49. Conticello SG, Harris RS, Neuberger MS. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 2003;13:2009-2013.
50. Cook RF, Leroux C, Cook SJ, et al. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J Virol 1998;72:1383-1393.
51. Corbet S, Muller-Trutwin MC, Versmisse P, et al. env sequences of simian immunodeficiency viruses from chimpanzees in cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol 2000;74:529-534.
52. Courgnaud V, Abela B, Pourrut X, et al. Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J Virol 2003;77:12523-12534.
53. Courgnaud V, Formenty P, Akoua-Koffi C, et al. Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from Western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus). J Virol 2003;77:744-748.
54. Courgnaud V, Pourrut X, Bibollet-Ruche F, et al. Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family. J Virol 2001;75:857-866.
55. Courgnaud V, Salemi M, Pourrut X, et al. Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J Virol 2002;76:8298-8309.
56. Covaleda L, Fuller FJ, Payne SL. EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages. Virology 2010;397:217-223.
57. Cranage MP, Ashworth LAE, Greenaway PJ, et al. AIDS vaccine developments. Nature 1992;355:684-686.
58. Cranage MP, Polyanskaya N, McBride B, et al. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses 1993;9:13-22.
59. Daniel M, Letvin N, Sehgal P, et al. Prevalence of antibodies to 3 retroviruses in a captive colony of macaque monkeys. Int J Cancer 1988;41:601-608.
60. Daniel MD, Kirchhoff F, Czajak SC, et al. Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
61. Daniel MD, Letvin NL, King NW, et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985;228:1201-1204.
62. Dazza MC, Ekwalanga M, Nende M, et al. Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti). J Virol 2005;79:8560-8571.
63. de Parseval A, Chatterji U, Morris G, et al. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol 2005;12:60-66.
64. de Parseval A, Chatterji U, Sun P, et al. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A 2004;101:13044-13049.
65. de Parseval A, Elder JH. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J Virol 1999;73:608-617.
66. de Rozieres S, Mathiason CK, Rolston MR, et al. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol 2004;78:8971-8982.
67. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-991.
68. DeGottardi MQ, Specht A, Metcalf B, et al. Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by Nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol 2008;82:3139-3146.
69. Desrosiers R, Lifson JD, Gibbs JS, et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol 1998;72:1431-1437.
70. Desrosiers RC. HIV-1 origins: A finger on the missing link. Nature 1990;345:288-289.
71. Desrosiers RC. Prospects for an AIDS vaccine. Nat Med 2004;10:221-223.
72. Desrosiers RC. Strategies used by human immunodeficiency virus that allow persistent viral replication. Nat Med 1999;5:723-725.
73. Desrosiers RC, Wyand MS, Kodama T, et al. Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 1989;86:6353-6357.
74. Dewhurst S, Embretson JE, Anderson DC, et al. Sequence analysis and acute pathogenicity of molecularly cloned SIVsmmPBj14. Nature 1990;345:636-640.
75. Dharma DM, Budiantono A, Campbell RS, et al. Studies on experimental Jembrana disease in Bali cattle. III. Pathology. J Comp Pathol 1991;105:397-414.
76. Dharma DM, Ladds PW, Wilcox GE, et al. Immunopathology of experimental Jembrana disease in Bali cattle. Vet Immunol Immunopathol 1994;44:31-44.
77. Donahue RE, Bunnell BA, Zink MC, et al. Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nat Med 1998;4:181-186.
78. Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002;417:95-98.
79. Douglas JL, Viswanathan K, McCarroll MN, et al. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 2009;83:7931-7947.
80. Dow SW, Poss ML, Hoover EA. Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr 1990;3:658-668.
81. Du Z, Lang SM, Sasseville VG, et al. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 1995;82:665-674.
82. Dunham R, Pagliardini P, Gordon S, et al. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 2006;108:209-217.
83. Dykhuizen M, Mitchen JL, Montefiori DC, et al. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J Gen Virol 1998;79:2461-2467.
84. Edinger AL, Mankowski JL, Doranz BJ, et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A 1997;94:14742-14747.
85. Elder JH, Lerner DL, Hasselkus-Light CS, et al. Distinct subsets of retroviruses encode dUTPase. J Virol 1992;66:1791-1794.
86. Emau P, McClure HM, Isahakia M, et al. Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses. J Virol 1991;65:2135-2140.
87. Evans DT, Desrosiers, RC. Immune evasion strategies of the primate lentiviruses. Immunol Rev 2001;183:141-158.
88. Evans DT, O'Connor DH, Jing P, et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med 1999;5:1270-1276.
89. Fitzpatrick K, Skasko M, Deerinck TJ, et al. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog 2010;6:e1000701.
90. Fletcher TM 3rd, Brichacek B, Sharova N, et al. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 1996;15:6155-6165.
91. Fomsgaard A, Hirsch VM, Allan JS, et al. A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Virology 1991;182:397-402.
92. Fukasawa M, Muira T, Hasegawa A, et al. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature 1988;333:457-461.
93. Fultz PN. Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes. J Virol 1991;65:4902-4909.
94. Fultz PN, McClure HM, Anderson DC, et al. Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A 1986;83:5286-5290.
95. Fultz PN, McClure HM, Anderson DC, et al. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses 1989;5:397-409.
96. Gabuzda DH, Lawrence K, Langhoff E, et al. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol 1992;66:6489-6495.
97. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441.
98. Gao F, Yue L, Robertson DL, et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994;68:7433-7447.
99. Gao F, Yue L, White AT, et al. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 1992;358:495-499.
100. Garcia J, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991;350:508-511.
101. Gauduin M-C, Glickman RL, Ahmad S, et al. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Proc Natl Acad Sci U S A 1999;96:14031-14036.
102. Gauduin MC, Yu Y, Barabasz A, et al. Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection. J Exp Med 2006;203:2661-2672.
103. Gemeniano MC, Sawai ET, Sparger EE. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest. Virology 2004;325:167-174.
104. Gendelman HE, Narayan O, Kennedy-Stoskopf S, et al. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 1986;58:67-74.
105. Georges-Courbot MC, Lu CY, Makuwa M, et al. Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus. J Virol 1998;72:600-608.
106. Gibbs JS, Lackner AA, Lang SM, et al. Progression to AIDS in the absence of genes for vpr or vpx. J Virol 1995;69:2378-2383.
107. Gifford RJ, Katzourakis A, Tristem M, et al. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc Natl Acad Sci U S A 2008;105:20362-20367.
108. Goldstein S, Ourmanov I, Brown CR, et al. Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus. J Virol 2000;74:11744-11753.
109. Gonda M. The Lentiviruses of Cattle. In: Levy JA, ed. Retroviridae, vol. 3. New York: Plenum Press, 1994
110. Gonda MA, Braun MJ, Carter SG, et al. Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus. Nature 1987;330:388-391.
111. Gonda MA, Charman HP, Walker JL, et al. Scanning and transmission electron microscopic study of equine infectious anemia virus. Am J Vet Res 1978;39:731-740.
112. Gonda MA, Wong-Staal F, Gallo RC, et al. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science 1985;227:173-177.
113. Gramberg T, Sunseri N, Landau NR. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J Virol 2010;84:1387-1396.
114. Greenough T, Sullivan JL, Desrosiers RC. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999;340:236-237.
115. Gudnadottir M, Palsson PA. Transmission of maedi by inoculation of a virus grown in tissue culture from maedi-affected lungs. J Infect Dis 1967;117:1-6.
116. Hammonds J, Wang JJ, Yi H, et al. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog 2010;6:e1000749.
117. Harmache A, Vitu C, Russo P, et al. The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J Virol 1995;69:5445-5454.
118. Harouse JM, Gettie A, Tan RC, et al. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999;284:816-819.
119. Harris RS, Bishop KN, Sheehy AM, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003;113:803-809.
120. Harris RS, Sheehy AM, Craig HM, et al. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat Immunol 2003;4:641-643.
121. Hatziioannou T, Perez-Caballero D, Yang A, et al. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 2004;101:10774-10779.
122. Hauser H, Lopez LA, Yang SJ, et al. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 2010;7:51.
123. He J, Choe S, Walker R, et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995;69:6705-6711.
124. Himathongkham SLP. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 1996;219:485-488.
125. Hirsch V, Adger-Johnson D, Campbell B, et al. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol 1997;71:1608-1620.
126. Hirsch VM, Campbell BJ, Bailes E, et al. Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses. J Virol 1999;73:1036-1045.
127. Hirsch VM, Dapolito G, Johnson PR, et al. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol 1995;69:955-967.
128. Hirsch VM, Dapolito GA, Goldstein S, et al. A distinct African lentivirus from Sykes' monkeys. J Virol 1993;67:1517-1528.
129. Hirsch VM, Olmsted RA, Murphey-Corb M, et al. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989;339:389-392.
130. Hirsch VM, Sharkey ME, Brown CR, et al. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med 1998;4:1401-1408.
131. Ho DD, Neuman AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
132. Hofmann W, Schubert D, LaBonte J, et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 1999;73:10020-10028.
133. Hong Y, Fink E, Hu QY, et al. OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection. J Virol 2010;84:7225-7232.
134. Hosie MJ, Broere N, Hesselgesser J, et al. Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. J Virol 1998;72:2097-2104.
135. Howe AY, Jung JU, Desrosiers RC. Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol 1998;72:9827-9834.
136. Hrecka K, Gierszewska M, Srivastava S, et al. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci U S A 2007;104:11778-11783.
137. Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011;474:658-661.
138. Hu J, Switzer WM, Foley BT, et al. Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. J Virol 2003;77:4867-4880.
139. Huet T, Cheynier R, Meyerhans A, et al. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 1990;345:356-359.
140. Igarashi T, Brown CR, Byrum RA, et al. Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV (DH12R) is systemic and synchronous. J Virol 2002;76:379-391.
141. Igarashi T, Endo Y, Englund G, et al. Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus. Proc Natl Acad Sci U S A 1999;96:14049-14054.
142. Igarashi T, Shibata R, Hasebe F, et al. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS Res Hum Retroviruses 1994;10:1021-1029.
143. Ilyinskii P, Desrosiers RC. Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kB and Sp1 binding elements. J Virol 1996;70:3118-3126.
144. Ilyinskii PO, Daniel MD, Simon MA, et al. The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J Virol 1994;68:5933-5944.
145. Ilyinskii PO, Simon MA, Czajak SC, et al. Induction of AIDS by simian immunodeficiency virus lacking NF-κB and SP1 binding elements. J Virol 1997;71:1880-1887.
146. Issel C, Foil LD. Studies on equine infectious anemia virus transmission by insects. J Am Vet Med Assoc 1984;184:293-297.
147. Iwabu Y, Fujita H, Kinomoto M, et al. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem 2009;284:35060-35072.
148. Janvier K, Pelchen-Matthews A, Renaud JB, et al. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. PLoS Pathog 2011;7:e1001265.
149. Jia B, Serra-Moreno R, Neidermyer W, et al. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 2009;5:e1000429.
150. Jin MJ, Hui H, Robertson DL, et al. Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J 1994;13:2935-2947.
151. Jin MJ, Rogers J, Phillips-Conroy JE, et al. Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: Evidence for cross-species transmission in the wild. J Virol 1994;68:8454-8460.
152. Joag SV, Li Z, Foresman L, et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol 1996;70:3189-3187.
153. Johnson PR, Fomsgaard A, Allan J, et al. Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. J Virol 1990;64:1086-1092.
154. Johnson PR, Schnepp BC, Zhang J, et al. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat Med 2009;15:901-906.
155. Johnson RP, Lifson JD, Czajak SC, et al. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relation of degree of protection with level of attenuation. J Virol 1999;73:4952-4961.
156. Johnson W, Desrosiers RC. Viral persistance: HIV's strategies of immune system evasion. Annu Rev Med 2002;53:499-518.
157. Jones T, Hunt RD, King NW. Veterinary Pathology. In: Cann C, ed. Baltimore: Williams and Wilkins, 1997:197-307.
158. Jowett JB, Planelles V, Poon B, et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 1995;69:6304-6313.
159. Katzourakis A, Tristem M, Pybus OG, et al. Discovery and analysis of the first endogenous lentivirus. Proc Natl Acad Sci U S A 2007;104:6261-6265.
160. Kaur A, Grant RM, Means RE, et al. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol 1998;72:9597-9611.
161. Keckesova Z, Ylinen LM, Towers GJ, et al. Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 2009;384:7-11.
162. Kertayadnya G, Wilcox GE, Soeharsono S, et al. Characteristics of a retrovirus associated with Jembrana disease in Bali cattle. J Gen Virol 1993;74:1765-1778.
163. Kestler H, Kodama T, Ringler D, et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990;248:1109-1112.
164. Kestler HW III, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 1991;65:651-662.
165. Kestler HW, Li Y, Naidu YM, et al. Comparison of simian immunodeficiency virus isolates. Nature (London) 1988;331:619-621.
166. Khabbaz RF, Heneine W, George JR, et al. Brief report: infection of a laboratory worker with simian immunodeficiency virus. N Engl J Med 1994;330:172-177.
167. Kilareski EM, Shah S, Nonnemacher MR, et al. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009;6:118.
168. Kirchhoff F, Greenough TC, Brettler DB, et al. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-232.
169. Kirchhoff F, Kestler HW III, Desrosiers RC. Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol 1994;68:2031-2037.
170. Kirmaier A, Wu F, Newman RM, et al. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 2010;8.
171. Klumpp SA, Novembre FJ, Anderson DC, et al. Clinical and pathologic findings in infant rhesus macaques infected with SIVsmm by maternal transmission. J Med Primatol 1993;22:169-176.
172. Kobayashi K. Studies on the cultivation of equine infectious anemia virus in vitro. I. Serial cultivation of the virus in the culture of various horse tissues. Virus 1961;11:177-189.
173. Kodama T, Silva DP, Daniel MD, et al. Prevalence of antibodies to SIV in baboons in their native habitat. AIDS Res Hum Retroviruses 1989;5(3):337-343.
174. Kupzig S, Korolchuk V, Rollason R, et al. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003;4:694-709.
175. Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
176. Lackner A, Vogel P, Ramos R, et al. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of SIV. Am J Pathol 1994;145:428-439.
177. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011;474:654-657.
178. Lang SM, Weeger M, Stahl-Henning C, et al. The importance of vpr for the infection of rhesus monkeys with simian immunodeficiency virus. J Virol 1993;67:902-912.
179. Le Rouzic E, Belaidouni N, Estrabaud E, et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 2007;6:182-188.
180. Le Tortorec A, Neil SJ. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 2009;83:11966-11978.
181. Learmont JC, Geczy AF, Mills J, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med 1999;340:1715-1722.
182. Lecossier D, Bouchonnet F, Clavel F, et al. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003;300:1112.
183. Leendertz SA, Locatelli S, Boesch C, et al. No evidence for transmission of SIVwrc from western red colobus monkeys (Piliocolobus badius badius) to wild West African chimpanzees (Pan troglodytes verus) despite high exposure through hunting. BMC Microbiol 2011;11:24.
184. Lemey P, Pybus OG, Wang B, et al. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci U S A 2003;100:6588-6592.
185. Lerner DL, Wagaman PC, Phillips TR, et al. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine- triphosphatase. Proc Natl Acad Sci U S A 1995;92:7480-7484.
186. Li F, Leroux C, Craigo JK, et al. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J Virol 2000;74:573-579.
187. Li F, Puffer BA, Montelaro RC. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J Virol 1998;72:8344-8348.
188. Li J, Lord C, Haseltine W, et al. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that express the HIV-1 envelope glycoprotein. J Acquir Immune Defic Syndr 1992;5:639-646.
189. Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005;434:1148-1152.
190. Li Y, Li X, Stremlau M, et al. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J Virol 2006;80:6738-6744.
191. Liao CH, Kuang YQ, Liu HL, et al. A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS 2007;21(Suppl 8):S19-26.
192. Lichtenstein DL, Rushlow KE, Cook RF, et al. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J Virol 1995;69:2881-2888.
193. Liddament MT, Brown WL, Schumacher AJ, et al. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr Biol 2004;14:1385-1391.
194. Lifson JD, Rossio JL, Arnaout R, et al. Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol 2000;74:2584-2593.
195. Lifson JD, Rossio JL, Piatak M Jr, et al. Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 2001;75:10187-10199.
196. Ling B, Apetrei C, Pandrea I, et al. Classic AIDS in a sooty mangabey after an 18-year natural infection. J Virol 2004;78:8902-8908.
197. Liu ZQ, Sheridan D, Wood C. Identification and characterization of the bovine immunodeficiency-like virus tat gene. J Virol 1992;66:5137-5140.
198. Locher CP, Barnett SW, Herndier BG, et al. Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. Arch Pathol Lab Med 1998;122:523-533.
199. Loffredo JT, Maxwell J, Qi Y, et al. Mamu-b*08-positive macaques control simian immunodeficiency virus replication. J Virol 2007;81:8827-8832.
200. Loffredo JT, Sidney J, Bean AT, et al. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 2009;182:7763-7775.
201. Lowenstine LJ, Lerche NW, Yee JL, et al. Evidence for a lentiviral etiology in an epizootic of immune deficiency and lymphoma in stump-tailed macaques (Macaca arctoides). J Med Primatol 1992;21:1-14.
202. Lowenstine LJ, Pedersen NC, Higgins J, et al. Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer 1986;38:563-574.
203. Luciw PA, Pratt-Lowe E, Shaw KE, et al. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci U S A 1995;92:7490-7494.
204. Ma J, Shi N, Jiang CG, et al. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity. Virology 2011;410:96-106.
205. Mangeat B, Gers-Huber G, Lehmann M, et al. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog 2009;5:e1000574.
206. Mangeat B, Turelli P, Caron G, et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003;424:99-103.
207. Mangeat B, Turelli P, Liao S, et al. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J Biol Chem 2004;279:14481-14483.
208. Mansfield KG, Lerch NW, Gardner MB, et al. Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J Med Primatol 1995;24:116-122.
209. Mansky LM, Preveral D, Selig L, et al. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J Virol 2000;74:7039-7047.
210. Mariani R, Chen D, Schrofelbauer B, et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003;114:21-31.
211. Marin M, Rose KM, Kozak SL, et al. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003;9:1398-1403.
212. Markovitz DM, Smith MJ, Hilfinger J, et al. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kB regulatory elements. J Virol 1992;66:5479-5484.
213. Marsh H. Progressive pneumonia in sheep. J Am Vet Med Assoc 1923;62:458-473.
214. Marx P. Unsolved Questions over the Origin of HIV and AIDS. ASM News 2005;71:15-17.
215. Marx PA, Li Y, Lerche NW, et al. Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a West African pet sooty mangabey. J Virol 1991;65:4480-4485.
216. Matano T, Shibata R, Siemon C, et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998;72:164-169.
217. Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005;434:1093-1097.
218. Maury W. Regulation of Equine Infectious Anemia Virus Expression. J Biomed Sci 1998:11-23.
219. McClure HM, Anderson DC, Gordon TP, et al. Natural simian immunodeficiency virus infection in nonhuman primates. Top Primatol 1992;3:425-438.
220. McEwan WA, McMonagle EL, Logan N, et al. Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. J Virol 2008;82:10953-10958.
221. McGuire TC, Crawford TB, Henson JB. Immunofluorescent localization of equine infectious anemia virus in tissue. Am J Pathol 1971;62:283-294.
222. McNatt MW, Zang T, Hatziioannou T, et al. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 2009;5:e1000300.
223. Means RE, Desrosiers RC. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J Virol 2000;74:11181-11190.
224. Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004;200:761-770.
225. Mitchell RS, Katsura C, Skasko MA, et al. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 2009;5:e1000450.
226. Miyakawa K, Ryo A, Murakami T, et al. BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog 2009;5:e1000700.
227. Montagnier L, Dauguet C, Axler C, et al. A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: structural and antigenic relatedness with equine infectious anemia virus. Ann Virol 1984;135E:119-134.
228. Montelaro RC, Ball JM, Rushlow KE. Equine Retroviruses. In: Levy JA, ed. The Retroviridae, vol. 2. New York: Plenum Press, 1993:257.
229. Morse BA, Carruth LM, Clements JE. Targeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo. J Virol 1999;73:37-45.
230. Mothe BR, Weinfurter J, Wang C, et al. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 2003;77:2736-2740.
231. Muller MC, Saksena NK, Nerrienet E, et al. Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. J Virol 1993;67:1227-1235.
232. Murphey-Corb M, Martin LN, Davison-Fairburn B, et al. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 1989;246:1293-1297.
233. Murphey-Corb M, Martin LN, Rangan SRS, et al. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (London) 1986;321:435-437.
234. Myers G, Wain-Hobson S, Henderson LE, et al. Human Retroviruses and AIDS, I-B ed. Los Alamos: Los Alamos Laboratories, 1994:1-10.
235. Nakayama EE, Miyoshi H, Nagai Y, et al. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol 2005;79:8870-8877.
236. Neel C, Etienne L, Li Y, et al. Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol 2010;84:1464-1476.
237. Neil SJ, Sandrin V, Sundquist WI, et al. An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2007;2:193-203.
238. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008;451:425-430.
239. Nerrienet E, Amouretti X, Muller-Trutwin MC, et al. Phylogenetic analysis of SIV and STLV type I in mandrills (Mandrillus sphinx): indications that intracolony transmissions are predominantly the result of male-to-male aggressive contacts. AIDS Res Hum Retroviruses 1998;14:785-796.
240. Newman RM, Hall L, Connole M, et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc Natl Acad Sci U S A 2006;103:19134-19139.
241. Newman RM, Hall L, Kirmaier A, et al. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog 2008;4:e1000003.
242. Nishimura Y, Igarashi T, Donau OK, et al. Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc Natl Acad Sci U S A 2004;101:12324-12329.
243. Nisole S, Lynch C, Stoye JP, et al. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A 2004;101:13324-13328.
244. Novembre FJ, Hirsch VM, McClure HM, et al. SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus. Virology 1992;186:783-787.
245. Novembre FJ, Johnson PR, Lewis MG, et al. Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol 1993;67:2466-2474.
246. Novembre FJ, Saucier M, Anderson DC, et al. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 1997;71:4086-4091.
247. O'Neil SP, Novembre FJ, Hill AB, et al. Progressive infection in a subset of HIV-1-positive chimpanzees. J Infect Dis 2000;182:1051-1062.
248. Oaks JL, McGuire TC, Ulibarri C, et al. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J Virol 1998;72:7263-7269.
249. Ohta Y, Masuda T, Tsujimoto H, et al. Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer 1988;41:115-122.
250. Olmsted RA, Barnes AK, Yamamoto JK, et al. Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A 1989;86:2448-2452.
251. Osterhaus AD, Pedersen N, van Amerongen G, et al. Isolation and partial characterization of a lentivirus from talapoin monkeys (Myopithecus talapoin). Virology 1999;260:116-124.
252. Pandrea I, Onanga R, Rouquet P, et al. Chronic SIV infection ultimately causes immunodeficiency in African non-human primates. AIDS 2001;15:2461-2462.
253. Parekh B, Issel CJ, Montelaro RC. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses. Virology 1980;107:520-525.
254. Parren PW, Burton DR. The antiviral activity of antibodies in vitro and in vivo. Adv Immunol 2001;77:195-262.
255. Payne SL, Qi XM, Shao H, et al. Disease induction by virus derived from molecular clones of equine infectious anemia virus. J Virol 1998;72:483-487.
256. Pedersen NC, Ho EW, Brown ML, et al. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-793.
257. Peeters M, Courgnaud V, Abela B, et al. Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis 2002;8:451-457.
258. Peeters M, Honore C, Huet T, et al. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS 1989;3:625-630.
259. Peluso R, Haase A, Stowring L, et al. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 1985;147:231-236.
260. Perez-Caballero D, Zang T, Ebrahimi A, et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009;139:499-511.
261. Petursson G, Turelli P, Matthiasdottir S, et al. Visna virus dUTPase is dispensable for neuropathogenicity. J Virol 1998;72:1657-1661.
262. Phillips-Conroy JE, Jolly CJ, Petros B, et al. Sexual transmission of SIVagm in wild grivet monkeys. J Med Primatol 1994;23:1-7.
263. Picker LJ, Hagen SI, Lum R, et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med 2004;200:1299-1314.
264. Pifat DY, Ennis WH, Ward JM, et al. Persistent infection of rabbits with bovine immunodeficiency-like virus. J Virol 1992;66:4518-4524.
265. Pisoni G, Quasso A, Moroni P. Phylogenetic analysis of small-ruminant lentivirus subtype B1 in mixed flocks: evidence for natural transmission from goats to sheep. Virology 2005;339:147-152.
266. Pizzato M, Helander A, Popova E, et al. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci U S A 2007;104:6812-6817.
267. Poeschla EM, Looney DJ. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J Virol 1998;72:6858-6866.
268. Pohlmann S, Floos S, Ilyinskii PO, et al. Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements. J Virol 1998;72: 5589-5598.
269. Polacino PS, Stallard V, Klaniecki JE, et al. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in macaques. J Virol 1999;73:8201-8215.
270. Popovic M, Sarngadharan MG, Read E, et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497-500.
271. Pu R, Coleman J, Omori M, et al. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 2001;15:1225-1237.
272. Ramachandran S. Early observations and research of Jembrana disease in Bali and other Indonesian islands. Presented at: Jembrana disease and the bovine lentiviruses, Canberra. 1997;75:5-9.
273. Re F, Braaten D, Franke EK, et al. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol 1995;69:6859-6864.
274. Reimann KA, Li JT, Veazey R, et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 1996;70:6922-6928.
275. Reitter J, Means RE, Desrosiers RC. A role for carbohydrates in immune evasion in AIDS. Nature Med 1998;4:679-684.
276. Rey-Cuille MA, Berthier JL, Bomsel-Demontoy MC, et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 1998;72:3872-3886.
277. Richardson J, Pancino G, Merat R, et al. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol 1999;73:3661-3671.
278. Richman DD, Wrin T, Little SJ, et al. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 2003;100:4144-4149.
279. Riddick NE, Hermann EA, Loftin LM, et al. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 2010;6.
280. Rogel ME, Wu LI, Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 1995;69:882-888.
281. Rong L, Zhang J, Lu J, et al. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol 2009;83:7536-7546.
282. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-1450.
283. Rosenberg ES, Walker BD. HIV type 1-specific helper T cells: A critical host defense. AIDS Res Hum Retroviruses 1998;14:S143-S147.
284. Rosenzweig M, Marks DF, Hempel D, et al. Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection. J Virol 1997;71:2740-2746.
285. Ross EK, Buckler-White AJ, Rabson AB, et al. Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: Distinct patterns of viral growth are determined by T-cell types. J Virol 1991;65:4350-4358.
286. Rossio JL, Esser MT, Suryanarayana K, et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 1998;72:7992-8001.
287. Saenz DT, Teo W, Olsen JC, et al. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins. J Virol 2005;79:15175-15188.
288. Sasseville V, Lackner AA. Neuropathogenesis of simian immunodeficiency virus infection in macaque monkeys. J Neurovirol 1997;3:1-9.
289. Sauter D, Schindler M, Specht A, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009;6:409-421.
290. Sawyer S, Emerman M, Malik HS. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog 2007;3:e197.
291. Sawyer SL, Emerman M, Malik HS. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2004;2:E275.
292. Sawyer SL, Wu LI, Emerman M, et al. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 2005;102:2832-2837.
293. Sayah DM, Sokolskaja E, Berthoux L, et al. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004;430:569-573.
294. Schaller T, Hue S, Towers GJ. An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J Virol 2007;81:11713-11721.
295. Schindler M, Munch J, Kutsch O, et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006;125:1055-1067.
296. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857-860.
297. Schoborg RV, Saltarelli MJ, Clements JE. A Rev protein is expressed in caprine arthritis encephalitis virus (CAEV)-infected cells and is required for efficient viral replication. Virology 1994;202:1-15.
298. Schrofelbauer B, Chen D, Landau NR. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc Natl Acad Sci U S A 2004;101:3927-3932.
299. Schrofelbauer B, Hakata Y, Landau NR. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc Natl Acad Sci U S A 2007;104:4130-4135.
300. Schwartz O, Marechal V, LeGall S, et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 nef protein. Nat Med 1996;2:338-342.
301. Sellon DC, Perry ST, Coggins L, et al. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes. J Virol 1992;66:5906-5913.
302. Serra-Moreno R, Jia B, Breed M, et al. Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 2011;9:46-57.
303. Shacklett BL, Luciw PA. Analysis of the vif gene of feline immunodeficiency virus. Virology 1994;204:860-867.
304. Sharova N, Wu Y, Zhu X, et al. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 2008;4:e1000057.
305. Sharp P, Shaw GM, Hahn BH. Simian immunodeficiency virus infection of chimpanzees. J Virol 2005;79:3891-3902.
306. Sheehy A, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003;9:1404-1407.
307. Sheehy AM, Gaddis NC, Choi JD, et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002;418:646-650.
308. Shen R, Wang Z. Development and use of an equine infectious anemia donkey leucocyte attenuated vaccine. In Tashjian R, ed. Equine Infectious Anemia: A National Review of Policies, Programs, and Future Objections. Amarillo: American Quarter Horse Association, 1985:135-248.
309. Shen X, Leutenegger CM, Stefano Cole K, et al. A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens. J Gen Virol 2007;88:2793-2799.
310. Shibata R, Kawamura M, Sakai H, et al. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 1991;65:3514-3520.
311. Shibata R, Sakai H, Kawamura M, et al. Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol 1995;76(Pt 11):2723-2730.
312. Shimojima M, Miyazawa T, Ikeda Y, et al. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 2004;303:1192-1195.
313. Sigurdsson B. Rida; a chronic encephalitis of sheep. With general remarks on infections which develop slowly and some of their special characteristics. Br Vet J 1954;110:354-358.
314. Sigurdsson B, Grimsson H, Palsson PA. Maedi, a chronic progressive infection of sheep's lungs. J Infect Dis 1952;90:233-241.
315. Sigurdsson B, Pálsson PA. Visna of sheep. A slow, demyelinating infection. Br J Exp Pathol 1958;39:519.
316. Sigurdsson B, Palsson PA, Grimsson H. Visna, a demyelinating transmissible disease of sheep. J Neuropathol Exp Neurol 1957;16:389-403.
317. Sigurdsson B, Thormar H, Pálsson PA. Cultivation of visna virus in tissue culture. Arch Gesamte Virusforsch 1960;10:368.
318. Simon JH, Miller DL, Fouchier RA, et al. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J 1998;17:1259-1267.
319. Smirnova N, Troyer JL, Schissler J, et al. Feline lentiviruses demonstrate differences in receptor repertoire and envelope structural elements. Virology 2005;342:60-76.
320. Soderberg K, Denekamp L, Nikiforow S, et al. A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase. J Virol 2002;76:5803-5806.
321. Soeharsono S. Current information on Jembrana disease distribution in Indonesia. Presented at: Jembrana disease and the bovine lentiviruses. ACIAR Proceedings, Canberra. 1997;75:72-75.
322. Soeharsono S, Wilcox GE, Dharma DM, et al. Species differences in the reaction of cattle to Jembrana disease virus infection. J Comp Pathol 1995;112:391-402.
323. Soeharsono S, Wilcox GE, Putra AA, et al. The transmission of Jembrana disease, a lentivirus disease of Bos javanicus cattle. Epidemiol Infect 1995;115:367-374.
324. Song B, Javanbakht H, Perron M, et al. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J Virol 2005;79:3930-3937.
325. Sotir M, Switzer W, Schable C, et al. Risk of occupational exposure to potentially infectious nonhuman primate materials and to simian immunodeficiency virus. J Med Primatol 1997;26:233-240.
326. Souquiere S, Bibollet-Ruche F, Robertson DL, et al. Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol 2001;75:7086-7096.
327. Srivastava S, Swanson SK, Manel N, et al. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog 2008;4:e1000059.
328. Stremlau M, Owens CM, Perron MJ, et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004;427:848-853.
329. Swigut T, Alexander L, Morgan J, et al. Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J Virol 2004;78:13335-13344.
330. Swigut T, Iafrate AJ, Muench J, et al. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression. J Virol 2000;74:5691-5701.
331. Takemura T, Ekwalanga M, Bikandou B, et al. A novel simian immunodeficiency virus from black mangabey (Lophocebus aterrimus) in the Democratic Republic of Congo. J Gen Virol 2005;86:1967-1971.
332. Threadgill DS, Steagall WK, Flaherty MT, et al. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J Virol 1993;67:2592-2600.
333. Tokarev AA, Munguia J, Guatelli JC. Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J Virol 2011;85:51-63.
334. Tomonaga K, Katahira J, Fukasawa M, et al. Isolation and characterization of simian immunodeficiency virus from African white-crowned mangabey monkeys (Cercocebus torquatus lunulatus). Arch Virol 1993;129:77-92.
335. Toohey K, Haase AT. The rev gene of visna virus is required for productive infection. Virology 1994;200:276-280.
336. Troyer JL, Pecon-Slattery J, Roelke ME, et al. Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions. J Virol 2004;78:3777-3791.
337. Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-4273.
338. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995;270:1197-1199.
339. Tsujimoto H, Hasegawa A, Maki N, et al. Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill. Nature 1989;341:539-541.
340. Turelli P, Guiguen F, Mornex JF, et al. dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol 1997;71:4522-4530.
341. Überla K, Stahl Hennig C, Böttiger D, et al. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A 1995;92:8210-8214.
342. Valas S, Benoit C, Guionaud C, et al. North American and French caprine arthritis-encephalitis viruses emerge from ovine maedi-visna viruses. Virology 1997;237:307-318.
343. Vallée H, Carré H. Sur la nature infectieuse de l'anaemie du cheval. Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences 1904;139:331-333.
344. Van Damme N, Goff D, Katsura C, et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008;3:245-252.
345. Van Der Maaten MJ, Boothe AD, Seger CL. Isolation of a virus from cattle with persistent lymphocytosis. J Nat Cancer Inst 1972;49:1649.
346. Van Heuverswyn F, Li Y, Neel C, et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006;444:164.
347. van Rensburg EJ, Engelbrecht S, Mwenda J, et al. Simian immunodeficiency viruses (SIVs) from eastern and southern Africa: detection of a SIVagm variant from a chacma baboon. J Gen Virol 1998;79:1809-1814.
348. van Rompay KK, Dailey PJ, Tarara RP, et al. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques. J Virol 1999;73:2947-2955.
349. VandeWoude S, O'Brien SJ, Hoover EA. Infectivity of lion and puma lentiviruses for domestic cats. J Gen Virol 1997;78(Pt 4):795-800.
350. VandeWoude S, Troyer J, Poss M. Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV. Vet Immunol Immunopathol 2010;134:25-32.
351. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998;280:427-431.
352. Veazey RS, Tham IC, Mansfield KG, et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000;74:57-64.
353. Verschoor EJ, Fagrouch Z, Bontjer I, et al. A novel simian immunodeficiency virus isolated from a Schmidt's guenon (Cercopithecus ascanius schmidti). J Gen Virol 2004;85:21-24.
354. Villet S, Bouzar BA, Morin T, et al. Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein. J Virol 2003;77:9632-9638.
355. Virgen CA, Kratovac Z, Bieniasz PD, et al. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A 2008;105:3563-3568.
356. von Gegerfelt AS, Liska V, Ray NB, et al. Persistent infection of rhesus macaques by the rev-independent Nef(-) simian immunodeficiency virus SIVmac239: replication kinetics and genomic stability. J Virol 1999;73:6159-6165.
357. von Schwedler U, Song J, Aiken C, et al. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol 1993;67:4945-4955.
358. Wagaman PC, Hasselkus-Light CS, Henson M, et al. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology 1993;196:451-457.
359. Wang X, Wang S, Lin Y, et al. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains. Arch Virol 2011;156:353-357.
360. Wang Z, Metcalf B, Ribeiro RM, et al. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys. J Virol 2006;80:2771-2783.
361. Wei X, Decker JM, Wang S, et al. Antibody neutralization and escape by HIV-1. Nature 2003;422:307-312.
362. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
363. Weiland F, Matheka HD, Coggins L, et al. Electron microscopic studies on equine infectious anemia virus (EIAV). Brief report. Arch Virol 1977;55:335-340.
364. Whatmore AM, Cook N, Hall GA, et al. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol 1995;69:5117-5123.
365. Wiegand HL, Doehle BP, Bogerd HP, et al. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J 2004;23:2451-2458.
366. Wilcox GE. Jembrana disease. Aust Vet J 1997;75:492-493.
367. Willett BJ, Hosie MJ, Neil JC, et al. Common mechanisms of infection by lentiviruses. Nature 1997;385:587.
368. Wilson SJ, Webb BL, Maplanka C, et al. Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J Virol 2008;82:7243-7247.
369. Wilson SJ, Webb BL, Ylinen LM, et al. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A 2008;105:3557-3562.
370. Wojcechowskyj JA, Yant LJ, Wiseman RW, et al. Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes. J Virol 2007;81:406-410.
371. Wyand MS, Manson K, Montefiori DC, et al. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol 1999;73:8356-8363.
372. Wykrzykowska JJ, Rosenzweig M, Veazey RS, et al. Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med 1998;187:1767-1778.
373. Yamamoto JK, Sparger E, Ho EW, et al. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989;194:213-220.
374. Yant LJ, Friedrich TC, Johnson RC, et al. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 2006;80:5074-5077.
375. Yap MW, Nisole S, Stoye JP. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr Biol 2005;15:73-78.
376. Ylinen LM, Keckesova Z, Webb BL, et al. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J Virol 2006;80:7332-7338.
377. Yu Q, Konig R, Pillai S, et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 2004;11:435-442.
378. Yu X, Yu Y, Liu B, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003;302: 1056-1060.
379. Zaunders J, Dyer WB, Churchill M. The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control. Curr Opin HIV AIDS 2011;6:151-156.
380. Zhang B, Jin S, Jin J, et al. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. Proc Natl Acad Sci U S A 2005;102:9918-9923.
381. Zhang B, Montelaro RC. Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells. J Virol 2009;83:2034-2037.
382. Zhang F, Wilson SJ, Landford WC, et al. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009;6:54-67.
383. Zhang H, Yang B, Pomerantz RJ, et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003;424:94-98.
384. Zheng YH, Irwin D, Kurosu T, et al. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 2004;78:6073-6076.